Work

Abstract C156: GRB7 is required for triple-negative breast cancer motility, invasion, and chemoresistance.

Year: 2011

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-11-c156

Authors: Orsi Giricz, Veronica Calvo, Stephanie C. Pero, David N. Krag, Joseph A. Sparano, Paraic A. Kenny

Institutions: Albert Einstein College of Medicine, University of Vermont, Montefiore Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2021913170

Cites:

Cited by: 1

Related to: 10